203 related articles for article (PubMed ID: 33981002)
1. The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.
Xu Q; Zhang J; Telfer BA; Zhang H; Ali N; Chen F; Risa B; Pearson AJ; Zhang W; Finegan KG; Ucar A; Giurisato E; Tournier C
Oncogene; 2021 Jun; 40(23):3929-3941. PubMed ID: 33981002
[TBL] [Abstract][Full Text] [Related]
2. Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner.
Jiang W; Cai F; Xu H; Lu Y; Chen J; Liu J; Cao N; Zhang X; Chen X; Huang Q; Zhuang H; Hua ZC
Protein Cell; 2020 Nov; 11(11):825-845. PubMed ID: 32144580
[TBL] [Abstract][Full Text] [Related]
3. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling.
Sawhney RS; Liu W; Brattain MG
J Cell Physiol; 2009 Apr; 219(1):152-61. PubMed ID: 19089993
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 engineering of ERK5 identifies its FAK/PYK2 dependent role in adhesion-mediated cell survival.
Ali M; Mutahir Z; Riaz A
Biochem Biophys Res Commun; 2019 May; 513(1):179-185. PubMed ID: 30952431
[TBL] [Abstract][Full Text] [Related]
5. Targeting of FAK Ser910 by ERK5 and PP1delta in non-stimulated and phorbol ester-stimulated cells.
Villa-Moruzzi E
Biochem J; 2007 Nov; 408(1):7-18. PubMed ID: 17692050
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of ERK5 targeting in triple negative breast cancer.
Ortiz-Ruiz MJ; Álvarez-Fernández S; Parrott T; Zaknoen S; Burrows FJ; Ocaña A; Pandiella A; Esparís-Ogando A
Oncotarget; 2014 Nov; 5(22):11308-18. PubMed ID: 25350956
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK.
Villa-Moruzzi E
Anal Cell Pathol (Amst); 2011; 34(3):101-12. PubMed ID: 21483099
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
10. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling.
Bhatt AB; Patel S; Matossian MD; Ucar DA; Miele L; Burow ME; Flaherty PT; Cavanaugh JE
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572742
[TBL] [Abstract][Full Text] [Related]
13. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
Shen M; Jiang YZ; Wei Y; Ell B; Sheng X; Esposito M; Kang J; Hang X; Zheng H; Rowicki M; Zhang L; Shih WJ; Celià-Terrassa T; Liu Y; Cristea I; Shao ZM; Kang Y
Cancer Cell; 2019 Jan; 35(1):64-80.e7. PubMed ID: 30612941
[TBL] [Abstract][Full Text] [Related]
14. FAK tyrosine 407 organized with integrin αVβ5 in Hs578Ts(i)8 advanced triple-negative breast cancer cells.
Payan I; McDonnell S; Torres HM; Steelant WF; Van Slambrouck S
Int J Oncol; 2016 May; 48(5):2043-54. PubMed ID: 26984508
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
[TBL] [Abstract][Full Text] [Related]
16. PKCθ-mediated serine/threonine phosphorylations of FAK govern adhesion and protrusion dynamics within the lamellipodia of migrating breast cancer cells.
Chadelle L; Liu J; Choesmel-Cadamuro V; Karginov AV; Froment C; Burlet-Schiltz O; Gandarillas S; Barreira Y; Segura C; Van Den Berghe L; Czaplicki G; Van Acker N; Dalenc F; Franchet C; Hahn KM; Wang X; Belguise K
Cancer Lett; 2022 Feb; 526():112-130. PubMed ID: 34826547
[TBL] [Abstract][Full Text] [Related]
17. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
[TBL] [Abstract][Full Text] [Related]
18. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
[TBL] [Abstract][Full Text] [Related]
19. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
[TBL] [Abstract][Full Text] [Related]
20. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
